HEALTH
Inhaled Insulin Plus Degludec an Option for Type 1 Diabetes
![Inhaled Insulin Plus Degludec an Option for Type 1 Diabetes](https://connecticutnewspress.com/wp-content/uploads/2024/06/12468-inhaled-insulin-plus-degludec-an-option-for-type-1-diabetes.jpg)
ORLANDO, Fla. — The inhaled insulin Afrezza combined with a long-acting basal analog offers a non-inferior insulin treatment option for people with type 1 diabetes, new phase 4 data suggest. Afrezza Inhalation Powder is a rapid-acting orally inhaled human insulin, approved by the US Food and Drug Administration in 2014 for treating adults with type …